Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04362150 · ClinicalTrials.gov registry record
Long-term Impact of Infection With Novel Coronavirus (COVID-19)
A clinical trial of COVID, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 800
- Enrollment target
- 1
- Study location
NCT04362150: Recruiting study of COVID, sponsored by University of California, San Francisco.
NCT04362150 is a study of COVID that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 800 participants, below the 2,546-participant average among 14 other COVID trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04362150, a study of COVID, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 800 participants
- Enrollment target
- 1
- Study location
Study Summary
LIINC is a study of volunteers who were previously infected with SARS-CoV-2 (also known as novel coronavirus or COVID-19) who have recovered from acute infection. The study is designed to provide a specimen bank of samples with carefully characterized clinical data. LIINC specimens will be used to examine multiple questions involving the virologic, immunologic, and host factors involved in COVID-19, with a focus on understanding variability in the long-term immune response between individuals.
Primary Outcome
The median age of study participants at enrollment.
Conditions Studied
Study Locations (1)
California
- Zuckerberg San Francisco General Hospital (ZSFG) - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2020-04-21 |
| Est. Completion | 2030-12-31 |
What NCT04362150 shows while recruiting
NCT04362150 is an observational study that tracks outcomes without assigning an intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap, below the 2,546-participant average among 14 other COVID trials with a reported enrollment target (69% lower).
The record links to 1 condition, with COVID appearing as the primary indexed condition, and to 0 interventions.
NCT04362150 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04362150 about?
NCT04362150 is a clinical study titled "Long-term Impact of Infection With Novel Coronavirus (COVID-19)". LIINC is a study of volunteers who were previously infected with SARS-CoV-2 (also known as novel coronavirus or COVID-19) who have recovered from acute infection. The study is designed to provide a specimen bank of samples with carefully characterized clinical data. LIINC specimens will be used to e...
What is the current status of trial NCT04362150?
This trial is currently recruiting. The enrollment target is 800 participants. The study started on 2020-04-21. Estimated completion is 2030-12-31.
What conditions does trial NCT04362150 study?
This clinical trial studies the following conditions: COVID.
Who is sponsoring clinical trial NCT04362150?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04362150 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04362150's enrollment target sits among peer trials
800 6th of 14 higher than 9 of 14 other COVID trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COVID trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel for the Detection of COVID-19 and Other Coronaviruses
RECRUITING
-
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
RECRUITING · Phase 3
-
Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test
RECRUITING · NA
-
A Study to Explore the Role of Gut Flora in COVID-19 Infection
RECRUITING
-
COVID-19 Biorepository
ACTIVE NOT RECRUITING
-
Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI